Multitherapeutic Area Challenges for the CRO
Ellie Brightman March 15, 2026
For many CROs, working across multitherapeutic areas isn’t a deliberate strategic shift, but a natural progression. A new sponsor arrives with a different indication. A long‑standing client expands their pipeline. A team that once focused on a single specialty suddenly finds itself supporting very different studies at the same time.